missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SLC38A1 (aa 5-70) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-62580 (PA5-62580. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Amino acid transporters play essential roles in the uptake of nutrients, production of energy, chemical metabolism, detoxification, and neurotransmitter cycling. SLC38A1 is an important transporter of glutamine, an intermediate in the detoxification of ammonia and the production of urea. Glutamine serves as a precursor for the synaptic transmitter, glutamate.
Specifications
Specifications
| Accession Number | Q9H2H9 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 81539 |
| Name | Human SLC38A1 (aa 5-70) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AA408026; AA409865; AL022800; Amino acid transporter A1; amino acid transporter system A1; ATA1; AU015942; GlnT; glutamine transporter; MNat2; Nat2; N-system amino acid transporter 2; rATA1; S38A1; Sa2; SAT1; SLC38A1; SNAT 1; Snat1; sodium-coupled neutral amino acid transporter 1; Solute carrier family 38 member 1; solute carrier family 38, member 1; system A amino acid transporter 1; System A transporter 2; system N amino acid transporter 1 |
| Common Name | SLC38A1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction